http://www.fda.gov/cder/orange/appendix_a.txt
2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN ...
Pharmaceutical Research and Manufacturers of America
(subsidiary of Hoechst A.G.) Ben Venue Laboratories Berlex Laboratories Berlex Laboratories Bertek Pharmaceuticals Bio-Technology General Bio-Technology General Bio-Technology General Biocodex BioCryst Pharmaceuticals Biogen BioMarin Pharmaceutical Biomedical Frontiers BioMedicines Biomira Biomira BioNumerick Pharmaceuticals Biopure Biopure Biopharmaceutics BioSante Pharmaceuticals...
Pharmaceutical Research and Manufacturers of America
(subsidiary of Hoechst A.G.) Ben Venue Laboratories Berlex Laboratories Berlex Laboratories Bertek Pharmaceuticals Bio-Technology General Bio-Technology General Bio-Technology General Biocodex BioCryst Pharmaceuticals Biogen BioMarin Pharmaceutical Biomedical Frontiers BioMedicines Biomira Biomira BioNumerick Pharmaceuticals Biopure Biopure Biopharmaceutics BioSante Pharmaceuticals...
Biogaia : BioGaia
Contact us Search- Business Consumer Health professional Press Investor Konsument Press Investerare - - Sverige - Koep produkt! USA - Go there! Subscribe to our Pressreleases Subscribe to our Newsletter BioGaia signs new agreement with Ferring Pharmaceuticals >>> BioGaia Year-end report 2007 >>> BioGaia Continues its Japanese Venture >>> Biogaia website does set cookies...
AR 2007 Lo Res.pdf page 69
Pages
Barr Laboratories, Inc. Additional Patent Challenges During fiscal 2003, we announced five additional patent challenges, including challenges for: Eli Lilly's Evista® product for the treatment and prevention of osteoporosis in postmenopausal women; Kos Pharmaceutical's Niaspan® 500 mg and 750 mg extended release tablets for cholesterol; Ferring 's patent related to...
author: Lisa
Pages page 5
author: Lisa
Salk Institute for Biological Studies
home : seminars and events - The Salk Institute extends its heartfelt appreciation to the following corporations, foundations, and individuals for their generous and loyal support as sponsors of Symphony at Salk 2004 galaxy benefactor * celestial patrons Maureen and Renato Dulbecco* - Senyei Family Foundation* - Jean and Steve Hamerslag* The Kohlberg Foundation, Inc Merck Research...
Salk Institute for Biological Studies
home : seminars and events - The Salk Institute extends its heartfelt appreciation to the following corporations, foundations, and individuals for their generous and loyal support as sponsors of Symphony at Salk 2003 Renato and Maureen Dulbecco Steve and Jean Hamerslag Senyei Family Foundation Signal Research Division of Celgene Ligand Pharmaceuticals Kathryn Colachis & JC Resorts...
Salk Institute for Biological Studies
home : about the salk institute : leadership - The Board of Trustees is composed of recognized leaders from the worlds business and non-profit communities who bring to the Institute a range of skills and perspectives. Trustees are charged with monitoring Institute operations to ensure that the organization fulfills its scientific and training missions and operates in a...
European Market Entry Strategies: Impact of Regulations, Pricing, Reimbursement, Parallel Trade and Generics Post-Accession
59 CHAPTER 2 EU15: IMPACT OF REGULATORY, PRICING AND REIMBURSEMENT POLICIES 60 Introduction 61 Overview of EU pharmaceutical regulation: two routes for market authorization 61 Role of the EMEA and the centralized procedure 61 Key functionalities of the centralized procedure 63 Role of CPMP 64 Role of COMP 65 MRP runs in parallel with the centralized procedure 65 Key functionalities...
author: BioPortfolio - Knowledge Management, Market Analysis and Market Research
Novel approaches for blocking metastasis
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
HMP-12 an adrenoceptor antagonist for the treatment of male and female sexual dysfunction
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
PK Solutions Pharmacokinetics Software at SummitPK.com
Pharmacokinetic Software for Research and Education PK Solutions pharmacokinetics software is a world-class solution for hundreds of users. Schering-Plough Research Inst. University of Queensland CMIC Co., Ltd. Sinai Medical Center Ferring Research Institute Dow Chemical Company Vertex Pharmaceuticals National Hospital Inst. Mehary Medical College Tulane University...
Microsoft Word - 2005-Notice of Meeting and Proxy Circular.DOC
DM_ VAN/ 253992- 00012/ 6341971. To be effective, Proxies must be deposited with the Toronto Office of the Corporation's registrar and transfer agent, Computershare Investor Services Inc., Proxy Dept., 100 University Avenue 9 th Floor, Toronto, Ontario, M5J 2Y1, before 10: 00 a. APPOINTMENT OF PROXIES A Shareholder has the right to designate a person (who need not be a...
author: cfondrick
Microsoft Word - 2005-Notice of Meeting and Proxy Circular.DOC page 8
author: cfondrick
BioPortfolio Limited
Markets in Human Reproductive Medicine Chapter one: Executive Summary Overview Scope and Methodology Contraception Management Contraceptive Use Worldwide Contraceptive Use in the U.S. ART Treatment Market ART Cycles of Treatment Performed in the United States U.S. History and Lines of Business Business Strategy Contraceptive Device Financial Information Ferring ...
Maternal screening for hypothyroidism and hypothroxinemia
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
BioPortfolio Limited
Urinary Track Agents Annual Report 2005 Table of Contents 1. 3.10.1 Harnal will be the Best-Selling UTA in 2004 3.10.2 Avodart will be the Fastest Grower in 2004 3.11 Alpha-Blockers Dominate the Market and will Continue to Do So 3.12 Benign Prostatic Hypertrophy is the Leading Indication for UTAs 3.13 There are Several Other Urinary Tract Agents on the Market, for Varying...
BioPortfolio Limited
7.4.1.4 Closing Notes on the Boehringer Ingelheim Case 7.4.2 Implementation of ECJ Judgment and Guidance From The UK Courts 7.4.2.1 UK Judgment on Repackaged Products 7.4.2.1.1Imitation Packaging 7.4.2.1.2Blank Packaging 7.4.2.2 UK Decision on Relabeling/Overstickering of Products Obtained by Parallel Importation 7.4.2.3 Required Notice to be Given when Relabeling 7.4.2.4 Closing...
BioPortfolio Limited
59 CHAPTER 2 EU15: IMPACT OF REGULATORY, PRICING AND REIMBURSEMENT POLICIES 60 Introduction 61 Overview of EU pharmaceutical regulation: two routes for market authorization 61 Role of the EMEA and the centralized procedure 61 Key functionalities of the centralized procedure 63 Role of CPMP 64 Role of COMP 65 MRP runs in parallel with the centralized procedure 65 Key functionalities...
BioPortfolio Limited
Parallel Trade In Global Pharma 2003 1. 8.1.4 Closing Notes on the Boehringer Ingelheim Case 8.2 Implementation of ECJ Judgment and Guidance From The UK Courts 8.2.1 UK Judgement on Repackaged Products 8.2.1a Imitation Packaging 8.2.1b Blank Packaging 8.2.1c De-branding 8.2.1d Co-Branding 8.2.2 UK Decision on Relabeling/Overstickering ofProducts Obtained by Parallel Importation 8...
BioPortfolio Limited
Pharmaceutical Pricing Global Perspectives Chapter 1: Pricing and the Pharmaceutical Market - The definition of price The functions of price The marketing mix - The product Case study: Lillys proactive strategy for patent expiry The place The rise of the Internet as a sales channel 8 The price Promotion The effect of price on the other elements of the marketing mix: the product...
BioPortfolio Limited
59 CHAPTER 2 EU15: IMPACT OF REGULATORY, PRICING AND REIMBURSEMENT POLICIES 60 Introduction 61 Overview of EU pharmaceutical regulation: two routes for market authorization 61 Role of the EMEA and the centralized procedure 61 Key functionalities of the centralized procedure 63 Role of CPMP 64 Role of COMP 65 MRP runs in parallel with the centralized procedure 65 Key functionalities...
Cardinal Health Annual Report 2004
2004 Online Annual Report Stakeholder Letter One Company Cardinal Health's Global Reach Executive Officers Financial Information Corporate & Investor Info One partner. 5 / 11 “The global outsourcing capabilities of Cardinal Health—covering pharmaceutical development, manufacturing and packaging services—extend the possibilities for our partnership.”...